BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 14742915)

  • 1. The pharmacology of adrenomedullin receptors and their relationship to CGRP receptors.
    Hay DL; Conner AC; Howitt SG; Smith DM; Poyner DR
    J Mol Neurosci; 2004; 22(1-2):105-13. PubMed ID: 14742915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.
    Hay DL; Howitt SG; Conner AC; Schindler M; Smith DM; Poyner DR
    Br J Pharmacol; 2003 Oct; 140(3):477-86. PubMed ID: 12970090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3.
    Robinson SD; Aitken JF; Bailey RJ; Poyner DR; Hay DL
    J Pharmacol Exp Ther; 2009 Nov; 331(2):513-21. PubMed ID: 19644039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
    Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
    J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The calcitonin receptor-like receptor/receptor activity-modifying protein 1 heterodimer can function as a calcitonin gene-related peptide-(8-37)-sensitive adrenomedullin receptor.
    Nagoshi Y; Kuwasako K; Ito K; Uemura T; Kato J; Kitamura K; Eto T
    Eur J Pharmacol; 2002 Aug; 450(3):237-43. PubMed ID: 12208315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CGRP receptors mediating CGRP-, adrenomedullin- and amylin-induced relaxation in porcine coronary arteries. Characterization with 'Compound 1' (WO98/11128), a non-peptide antagonist.
    Hasbak P; Sams A; Schifter S; Longmore J; Edvinsson L
    Br J Pharmacol; 2001 Aug; 133(8):1405-13. PubMed ID: 11498528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian calcitonin receptor-like receptor/receptor activity modifying protein complexes define calcitonin gene-related peptide and adrenomedullin receptors in Drosophila Schneider 2 cells.
    Aldecoa A; Gujer R; Fischer JA; Born W
    FEBS Lett; 2000 Apr; 471(2-3):156-60. PubMed ID: 10767413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
    Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
    Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins.
    Born W; Fischer JA; Muff R
    Recept Channels; 2002; 8(3-4):201-9. PubMed ID: 12529937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C; Gangula PR; Dong YL; Yallampalli C
    Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus.
    Nikitenko LL; Brown NS; Smith DM; MacKenzie IZ; Bicknell R; Rees MC
    Mol Hum Reprod; 2001 Jul; 7(7):655-64. PubMed ID: 11420389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP1.
    Bühlmann N; Leuthäuser K; Muff R; Fischer JA; Born W
    Endocrinology; 1999 Jun; 140(6):2883-90. PubMed ID: 10342881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
    Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
    Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequencing of a calcitonin receptor-like receptor in salmon Oncorhynchus gorbuscha. Functional studies using the human receptor activity-modifying proteins.
    Pidoux E; Cressent M
    Gene; 2002 Oct; 298(2):203-10. PubMed ID: 12426108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The seven amino acids of human RAMP2 (86) and RAMP3 (59) are critical for agonist binding to human adrenomedullin receptors.
    Kuwasako K; Kitamura K; Ito K; Uemura T; Yanagita Y; Kato J; Sakata T; Eto T
    J Biol Chem; 2001 Dec; 276(52):49459-65. PubMed ID: 11591721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenomedullin selectivity of calcitonin-like receptor/receptor activity modifying proteins.
    Muff R; Born W; Fischer JA
    Hypertens Res; 2003 Feb; 26 Suppl():S3-8. PubMed ID: 12630805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of human CRLR at Asn123 is required for ligand binding and signaling.
    Kamitani S; Sakata T
    Biochim Biophys Acta; 2001 May; 1539(1-2):131-9. PubMed ID: 11389975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.